EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Examining the interaction between area-level immunity coverage and individual-level immunity to help quantify indirect herd benefits: a population-based retrospective cohort study of COVID-19 diagnoses and deaths

Linwei Wang iD, Sarah Swayze iD, Arjumand Siddiqi iD, Stefan D Baral iD, Beate Sander iD, Hind Sbihi iD, Jeffrey C Kwong iD, Sharmistha Mishra iD

American Journal of Epidemiology · 08.07.2026 · 195 (7) · 2020-2028

DOI: 10.1093/aje/kwag047 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift American Journal of Epidemiology, online erschienen am 07.03.2026. Verfasst von Linwei Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: MAP-Centre for Urban Health Solutions, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: COVID-19, Immunity, Herd, COVID-19 Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Empirical evidence on the indirect herd benefits of COVID-19 vaccination and/or prior infection is limited. We examined how area-level immunity interacts with individual-level immunity to affect COVID-19 diagnoses and deaths. Ontario residents aged ≥18 years were followed from August 1, 2021, to January 30, 2022. Individual-level immunity was defined as receipt of a primary series of COVID-19 vaccines or a positive SARS-CoV-2 test in the past 165 days. Area-level immunity was based on the proportion of immune individuals in an individual's residing area. Logistic regression and cause-specific hazard models were used to examine the relationship between immunity and COVID-19 diagnosis, and between immunity and COVID-19 death, with an interaction term between individual-level and area-level immunity. Of 11 122 816 adults, 7 518 015 (67.6%) were classified as having individual-level immunity at baseline. After accounting for potential confounders, area-level immunity (highest vs. lowest quintiles) was associated with lower odds of COVID-19 diagnosis. Higher area-level immunity (highest vs. lowest quintiles) was also associated with lower hazard of COVID-19 death among non-immune individuals (hazard ratio, 0.77 [0.60, 1.00]). Findings provide evidence supporting the herd benefits of vaccination or prior infection on COVID-19 diagnosis and deaths, and provide insights for interpreting vaccine effectiveness estimates in the context of herd immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Immunity, HerdCOVID-19 VaccinesHumansFemaleOntarioRetrospective StudiesAdultMiddle AgedMaleAgedVaccinationSARS-CoV-2AdolescentYoung Adult

Stichwörter der Autor:innen

COVID-19SARS-CoV-2herd immunityimmune saturationindirect benefitsprior infectionvaccinationvaccine effectiveness

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • MAP-Centre for Urban Health Solutions, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
  • Populations & Public Health Research Program, ICES, Toronto, ON, Canada.
  • Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
  • Department of Paediatrics, Hospital for Sick Children, Toronto, ON, Canada.
  • Department of Social and Behavioural Sciences, Harvard School of Public Health, Boston, MA, United States.
  • Gillings School of Global Public Health, University of North Carolina - Chapel Hill, NC, United States.

ORCID-Profile: Linwei Wang, Sarah Swayze, Arjumand Siddiqi, Stefan D Baral, Beate Sander, Hind Sbihi, Jeffrey C Kwong, Sharmistha Mishra

Förderung

  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Wang, L., Swayze, S., Siddiqi, A., Baral, S. D., Sander, B., Sbihi, H., Kwong, J. C., & Mishra, S. (2026). Examining the interaction between area-level immunity coverage and individual-level immunity to help quantify indirect herd benefits: a population-based retrospective cohort study of COVID-19 diagnoses and deaths. American Journal of Epidemiology, 195(7), 2020-2028. https://doi.org/10.1093/aje/kwag047

Vancouver

Wang L, Swayze S, Siddiqi A, Baral SD, Sander B, Sbihi H, et al. Examining the interaction between area-level immunity coverage and individual-level immunity to help quantify indirect herd benefits: a population-based retrospective cohort study of COVID-19 diagnoses and deaths. American Journal of Epidemiology. 2026;195(7):2020-2028. doi:10.1093/aje/kwag047

BibTeX
@article{Wang2026,
  author = {Wang, Linwei and Swayze, Sarah and Siddiqi, Arjumand and Baral, Stefan D and Sander, Beate and Sbihi, Hind and Kwong, Jeffrey C and Mishra, Sharmistha},
  title = {Examining the interaction between area-level immunity coverage and individual-level immunity to help quantify indirect herd benefits: a population-based retrospective cohort study of COVID-19 diagnoses and deaths},
  journal = {American Journal of Epidemiology},
  year = {2026},
  volume = {195},
  number = {7},
  pages = {2020--2028},
  doi = {10.1093/aje/kwag047}
}
Kostenlos starten →